Primary record
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,14,17-trihydroxy-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,14-tetraene-15-carboxamide
- 库存
- 5,658 克
- 纯度
- 99.5 %
- CAS
- 916072-89-4
化合物标识与属性
- CAS
- 916072-89-4
- PubChem CID
- 54732242
- SMILES
- CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C([C@H]4[C@@]56CCN([C@@H]([C@@]5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O
- Canonical SMILES
- CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1
名称与同义词
- NALDEMEDINE
- Symproic
- naldemedina
- naldemedinum
- nalmedine
- Naldemedine [USAN]
- 03KSI6WLXH
- naldemedine tosilate
- Naldemedine tosylate
- UNII-03KSI6WLXH
- Naldemedine [USAN:INN]
- RefChem:57227
- 916072-89-4
- NALDEMEDINE [MI]
- NALDEMEDINE [INN]
- Naldemedine (USAN/INN)
- D0Q3PD
- NALDEMEDINE [WHO-DD]
- DTXSID501030350
- GTPL9150
- orb1695970
- SCHEMBL9880572
- CHEMBL2105755
- SCHEMBL29376271
- A06AH05
- S-297995
- DTXCID601515444
- EX-A10201A
- BDBM50503604
- EBC-27332
- MFCD30532638
- S 297995
- AKOS032945757
- S-297,995
- DB11691
- compound 9k [PMID: 30446313]
- DA-67333
- HY-19627
- CS-0016072
- NS00073301
- J3.573.009E
- D10188
- (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,7,9-trihydroxy-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-6-carboxamide
- EN300-20605629
- A1041265
- Q6960846
- Morphinan-7-carboxamide, 17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14- trihydroxy-N-(1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)-,(5alpha)-
- 17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-(2-(3-phenyl- 1,2,4-oxadiazol-5-yl)propan-2-yl)morphinan-7-carboxamide
- (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,14,17-trihydroxy-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,14-tetraene-15-carboxamide
- (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,14,17-trihydroxy-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18),14-tetraene-15-carboxamide
- (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,7,9-trihydroxy-N-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl)-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro(3,2-e)isoquinoline-6-carboxamide
- (5alpha)-17-(Cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-(1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)morphinan-7-carboxamide
- (5R)-17-(Cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-[1-(3-phenyl-1,2,4-oxadiazole-5-yl)-1-methylethyl]morphinan-7-carboxamide
- 17-(CYCLOPROPYLMETHYL)-6,7-DIDEHYDRO-4,5A-EPOXY-3,6,14-TRIHYDROXY-N-(2-(3-PHENYL-1,2,4-OXADIAZOL-5-YL)PROPAN-2-YL)MORPHINAN-7-CARBOXAMIDE
- 17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl)morphinan-7-carboxamide
- 17-(Cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-[1-(3-phenyl-1,2,4-oxadiazole-5-yl)-1-methylethyl]morphinan-7-carboxamide
- 17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-[2-(3-phenyl- 1,2,4-oxadiazol-5-yl)propan-2-yl]morphinan-7-carboxamide
- Nalmedine; (5alpha)-17-(Cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]-Morphinan-7-carboxamide;